Ceo Roundtable On Cancer Inc
EIN: 651230448 · Morrisville, NC · NTEE: G30
Is Ceo Roundtable On Cancer Inc Legit?
Insufficient Data
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
About Ceo Roundtable On Cancer Inc
Ceo Roundtable On Cancer Inc (EIN: 651230448) is a nonprofit organization based in Morrisville, NC, classified under NTEE code G30. The organization reported total revenue of $782K and total assets of $2.5M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Ceo Roundtable On Cancer Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Ceo Roundtable On Cancer Inc is a small nonprofit that has been operating for 21 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 3.3%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $1.8M |
| Total Expenses | $2.2M |
| Surplus / Deficit | $-412,053 |
| Total Assets | $3.4M |
| Total Liabilities | $128K |
| Net Assets | $3.2M |
| Operating Margin | -22.9% |
| Debt-to-Asset Ratio | 3.8% |
| Months of Reserves | 18.2 months |
Financial Health Grade: B
In 2023, Ceo Roundtable On Cancer Inc reported a deficit of $412K with expenses exceeding revenue, holds 18.2 months of operating reserves (strong position), has a debt-to-asset ratio of 3.8% (very low leverage).
Financial Trends
Over 13 years of filings (2011–2023), Ceo Roundtable On Cancer Inc's revenue has grown at a compound annual growth rate (CAGR) of 3.3%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +9.6% | +39.9% | -9.2% |
| 2022 | -45.8% | -12.8% | -0.2% |
| 2021 | +17.6% | -36.0% | +47.5% |
| 2020 | -47.4% | -42.7% | -19.3% |
| 2019 | +24.5% | +23.8% | -37.1% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1200 |
| IRS Ruling Date | 2005 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Analysis Pending
AI enrichment for Ceo Roundtable On Cancer Inc has not yet been completed. Basic IRS 990 data is shown below. Check back later for a full transparency report including a Mission Score, spending breakdown, executive compensation analysis, and red flags assessment.
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Ceo Roundtable On Cancer Inc with a Mission Score of 0 out of 100 (Very Poor). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a deficit of $412K, with expenses exceeding revenue.
- Debt-to-asset ratio: 3.8%.
Frequently Asked Questions about Ceo Roundtable On Cancer Inc
Is Ceo Roundtable On Cancer Inc a legitimate charity?
Based on AI analysis of IRS 990 filings, Ceo Roundtable On Cancer Inc (EIN: 651230448) insufficient data. 0 red flags identified, 0 strengths noted.
How does Ceo Roundtable On Cancer Inc spend its money?
Detailed spending breakdown data is not yet available for Ceo Roundtable On Cancer Inc. Check back for updated IRS 990 analysis.
Are donations to Ceo Roundtable On Cancer Inc tax-deductible?
Ceo Roundtable On Cancer Inc is registered as a tax-exempt nonprofit (EIN: 651230448). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
Filing History
IRS 990 filing history for Ceo Roundtable On Cancer Inc showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), Ceo Roundtable On Cancer Inc's revenue has grown by 48.1%, moving from $1.2M to $1.8M. Total assets increased by 115.6% over the same period, from $1.6M to $3.4M. Total functional expenses rose by 81.1%, from $1.2M to $2.2M. In its most recent filing year (2023), Ceo Roundtable On Cancer Inc reported a deficit of $412K, with expenses exceeding revenue. The organization holds $128K in liabilities against $3.4M in assets (debt-to-asset ratio: 3.8%), resulting in net assets of $3.2M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $1.8M | $2.2M | $3.4M | $128K | — | — |
| 2022 | $1.6M | $1.6M | $3.7M | $58K | — | View 990 |
| 2021 | $3.0M | $1.8M | $3.7M | $408K | — | View 990 |
| 2020 | $2.6M | $2.8M | $2.5M | $426K | — | — |
| 2019 | $4.9M | $4.9M | $3.1M | $1.2M | — | View 990 |
| 2018 | $3.9M | $4.0M | $5.0M | $3.0M | — | View 990 |
| 2017 | $3.2M | $3.2M | $2.4M | $319K | — | View 990 |
| 2016 | $2.4M | $2.9M | $2.5M | $454K | — | View 990 |
| 2015 | $2.7M | $2.5M | $2.9M | $305K | — | View 990 |
| 2014 | $2.7M | $1.7M | $2.6M | $168K | — | View 990 |
| 2013 | $1.2M | $1.2M | $1.5M | $81K | — | View 990 |
| 2012 | $1.3M | $1.3M | $1.7M | $267K | — | View 990 |
| 2011 | $1.2M | $1.2M | $1.6M | $98K | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $1.8M, expenses of $2.2M, and assets of $3.4M (revenue +9.6% year-over-year).
- 2022: Revenue of $1.6M, expenses of $1.6M, and assets of $3.7M (revenue -45.8% year-over-year).
- 2021: Revenue of $3.0M, expenses of $1.8M, and assets of $3.7M (revenue +17.6% year-over-year).
- 2020: Revenue of $2.6M, expenses of $2.8M, and assets of $2.5M (revenue -47.4% year-over-year).
- 2019: Revenue of $4.9M, expenses of $4.9M, and assets of $3.1M (revenue +24.5% year-over-year).
- 2018: Revenue of $3.9M, expenses of $4.0M, and assets of $5.0M (revenue +21.8% year-over-year).
- 2017: Revenue of $3.2M, expenses of $3.2M, and assets of $2.4M (revenue +35.2% year-over-year).
- 2016: Revenue of $2.4M, expenses of $2.9M, and assets of $2.5M (revenue -10.1% year-over-year).
- 2015: Revenue of $2.7M, expenses of $2.5M, and assets of $2.9M (revenue -0.6% year-over-year).
- 2014: Revenue of $2.7M, expenses of $1.7M, and assets of $2.6M (revenue +121.0% year-over-year).
- 2013: Revenue of $1.2M, expenses of $1.2M, and assets of $1.5M (revenue -4.4% year-over-year).
- 2012: Revenue of $1.3M, expenses of $1.3M, and assets of $1.7M (revenue +4.0% year-over-year).
- 2011: Revenue of $1.2M, expenses of $1.2M, and assets of $1.6M.
Data Sources and Methodology
This transparency report for Ceo Roundtable On Cancer Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.